192 related articles for article (PubMed ID: 15604515)
1. APOA5 polymorphisms influence plasma triglycerides in young, healthy African Americans and whites of the CARDIA Study.
Klos KL; Hamon S; Clark AG; Boerwinkle E; Liu K; Sing CF
J Lipid Res; 2005 Mar; 46(3):564-71. PubMed ID: 15604515
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks.
Hodoglugil U; Tanyolaç S; Williamson DW; Huang Y; Mahley RW
J Lipid Res; 2006 Jan; 47(1):144-53. PubMed ID: 16258166
[TBL] [Abstract][Full Text] [Related]
3. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease.
Lee KW; Ayyobi AF; Frohlich JJ; Hill JS
Atherosclerosis; 2004 Sep; 176(1):165-72. PubMed ID: 15306190
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
5. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study.
Lai CQ; Demissie S; Cupples LA; Zhu Y; Adiconis X; Parnell LD; Corella D; Ordovas JM
J Lipid Res; 2004 Nov; 45(11):2096-105. PubMed ID: 15342688
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans.
Chandak GR; Ward KJ; Yajnik CS; Pandit AN; Bavdekar A; Joglekar CV; Fall CH; Mohankrishna P; Wilkin TJ; Metcalf BS; Weedon MN; Frayling TM; Hattersley AT
BMC Med Genet; 2006 Oct; 7():76. PubMed ID: 17032446
[TBL] [Abstract][Full Text] [Related]
7. Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population.
Moreno-Luna R; Perez-Jimenez F; Marin C; Perez-Martinez P; Gomez P; Jimenez-Gomez Y; Delgado-Lista J; Moreno JA; Tanaka T; Ordovas JM; Lopez-Miranda J
J Clin Endocrinol Metab; 2007 Jun; 92(6):2280-5. PubMed ID: 17356049
[TBL] [Abstract][Full Text] [Related]
8. Relationship of APOA5, PPARγ and HL gene variants with serial changes in childhood body mass index and coronary artery disease risk factors in young adulthood.
Ramakrishnan L; Sachdev HS; Sharma M; Abraham R; Prakash S; Gupta D; Singh Y; Bhaskar S; Sinha S; Chandak GR; Reddy KS; Santosh B
Lipids Health Dis; 2011 May; 10():68. PubMed ID: 21548985
[TBL] [Abstract][Full Text] [Related]
9. Effects of polymorphisms in APOA5 on the plasma levels of triglycerides and risk of coronary heart disease in Jilin, northeast China: a case-control study.
You Y; Wu YH; Zhang Y; Zhang L; Song Y; Bai W; Li Y; Yu Y; Kou C
BMJ Open; 2018 Jun; 8(6):e020016. PubMed ID: 29866721
[TBL] [Abstract][Full Text] [Related]
10. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease.
Jang Y; Paik JK; Hyun YJ; Chae JS; Kim JY; Choi JR; Lee SH; Shin DJ; Ordovas JM; Lee JH
Clin Chim Acta; 2009 Apr; 402(1-2):83-7. PubMed ID: 19159622
[TBL] [Abstract][Full Text] [Related]
11. The polymorphisms -1131T>C and the S19W of the APOA5 gene are not associated with coronary artery disease in a Brazilian population.
Prochaska CL; Picheth G; Anghebem-Oliveira MI; Costantini CO; de Souza EM; Pedrosa FO; Scartezini M
Clin Chem Lab Med; 2010 Mar; 48(3):419-22. PubMed ID: 20170397
[No Abstract] [Full Text] [Related]
12. Gender and ethnic differences in a case-control study of dyslipidemia: using the apolipoprotein A-V gene as an exemplar in cardiovascular genetics.
Wung SF; Aouizerat BE
Res Theory Nurs Pract; 2003; 17(4):281-99; discussion 335-8. PubMed ID: 14959997
[TBL] [Abstract][Full Text] [Related]
13. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
14. A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population.
Tang Y; Sun P; Guo D; Ferro A; Ji Y; Chen Q; Fan L
Atherosclerosis; 2006 Apr; 185(2):433-7. PubMed ID: 16046221
[TBL] [Abstract][Full Text] [Related]
15. A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese.
Bi N; Yan SK; Li GP; Yin ZN; Chen BS
Mol Genet Metab; 2004 Nov; 83(3):280-6. PubMed ID: 15542401
[TBL] [Abstract][Full Text] [Related]
16. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.
Talmud PJ; Hawe E; Martin S; Olivier M; Miller GJ; Rubin EM; Pennacchio LA; Humphries SE
Hum Mol Genet; 2002 Nov; 11(24):3039-46. PubMed ID: 12417525
[TBL] [Abstract][Full Text] [Related]
17. The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes.
Dorfmeister B; Cooper JA; Stephens JW; Ireland H; Hurel SJ; Humphries SE; Talmud PJ
Biochim Biophys Acta; 2007 Mar; 1772(3):355-63. PubMed ID: 17197160
[TBL] [Abstract][Full Text] [Related]
18. Contrasting multi-site genotypic distributions among discordant quantitative phenotypes: the APOA1/C3/A4/A5 gene cluster and cardiovascular disease risk factors.
Payseur BA; Clark AG; Hixson J; Boerwinkle E; Sing CF
Genet Epidemiol; 2006 Sep; 30(6):508-18. PubMed ID: 16800005
[TBL] [Abstract][Full Text] [Related]
19. Association of PON1 and APOA5 gene polymorphisms in a cohort of Indian patients having coronary artery disease with and without type 2 diabetes.
Bhaskar S; Ganesan M; Chandak GR; Mani R; Idris MM; Khaja N; Gulla S; Kumar U; Movva S; Vattam KK; Eppa K; Hasan Q; Pulakurthy UR
Genet Test Mol Biomarkers; 2011; 15(7-8):507-12. PubMed ID: 21438666
[TBL] [Abstract][Full Text] [Related]
20. Effects of Polymorphisms in APOA4-APOA5-ZNF259-BUD13 Gene Cluster on Plasma Levels of Triglycerides and Risk of Coronary Heart Disease in a Chinese Han Population.
Fu Q; Tang X; Chen J; Su L; Zhang M; Wang L; Jing J; Zhou L
PLoS One; 2015; 10(9):e0138652. PubMed ID: 26397108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
